Nosso grupo organiza mais de 3.000 Séries de conferências Eventos todos os anos nos EUA, Europa e outros países. Ásia com o apoio de mais 1.000 Sociedades e publica mais de 700 Acesso aberto Periódicos que contém mais de 50.000 personalidades eminentes, cientistas de renome como membros do conselho editorial.

Periódicos de acesso aberto ganhando mais leitores e citações
700 periódicos e 15 milhões de leitores Cada periódico está obtendo mais de 25.000 leitores

Abstrato

Biomedical Uses for Engineered Heparin-Based Materials

Cheng Liu

Engineered heparin-based biomaterials have emerged as a versatile and promising class of materials with diverse biomedical applications. Leveraging the inherent bioactivity of heparin and advances in material engineering, researchers have developed tailored biomaterials that exhibit unique properties for applications ranging from drug delivery and tissue engineering to wound healing and diagnostics [1]. This article provides a comprehensive overview of the multifaceted potential of engineered heparin-based biomaterials. It explores their design principles, interactions with biological systems, and implications for various biomedical domains. Through a synthesis of current research, this article highlights the transformative impact of these biomaterials and discusses their role in shaping the future of modern medicine [2].